1.上海中医药大学附属曙光医院(上海 201203)
陆立群,女,硕士,住院医师,主要从事中西医结合防治糖尿病及其并发症的临床研究
徐隽斐,副主任医师;E-mail: Junfei.xu@shsgyy-endo.cn
扫 描 看 全 文
陆立群,金燊懿,闫子惠等.健脾清化方对气阴两虚型初发2型糖尿病患者TIR及四肢骨骼肌的影响[J].上海中医药大学学报,2023,37(03):19-24.
LU Liqun,JIN Shenyi,YAN Zihui,et al.Effect of Jianpi Qinghua Formula on TIR and skeletal muscle of extremities in patients of initial type 2 diabetes with type of qi and yin deficiency[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(03):19-24.
陆立群,金燊懿,闫子惠等.健脾清化方对气阴两虚型初发2型糖尿病患者TIR及四肢骨骼肌的影响[J].上海中医药大学学报,2023,37(03):19-24. DOI: 10.16306/j.1008-861x.2023.03.004.
LU Liqun,JIN Shenyi,YAN Zihui,et al.Effect of Jianpi Qinghua Formula on TIR and skeletal muscle of extremities in patients of initial type 2 diabetes with type of qi and yin deficiency[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(03):19-24. DOI: 10.16306/j.1008-861x.2023.03.004.
目的,2,探讨健脾清化方对初发气阴两虚型2型糖尿病(T2DM)患者的血糖波动、骨骼肌含量及功能的影响。,方法,2,纳入70例初发气阴两虚型T2DM患者,随机分为治疗组和对照组,每组各35例。两组患者均给予生活方式干预,在此基础上,治疗组患者予健脾清化方口服,对照组患者予安慰剂口服,疗程均为12周。治疗后,评价并比较两组患者的临床疗效;治疗前后,比较两组患者的中医证候总积分,检测患者的血糖在目标范围内时间(TIR)、四肢骨骼肌质量、优势手握力及糖化血红蛋白(HbA1c)、空腹血糖(FBG)、餐后2 h血糖(2 h PBG)水平。,结果,2,研究过程中,治疗组2例患者、对照组1例患者脱落或剔除,最终纳入统计分析者治疗组33例、对照组34例。①治疗后,治疗组的临床总有效率为75.8%,对照组为38.2%,治疗组的疗效优于对照组(,P,<,0.01)。②治疗后,治疗组患者的中医证候总积分较治疗前降低(,P,<,0.05),且治疗组患者的中医证候总积分改善情况优于对照组(,P,<,0.05)。③治疗后,治疗组患者的TIR有上升趋势,但治疗前后差异无统计学意义(,P,>,0.05),对照组患者的TIR显著下降(,P,<,0.05),且治疗组患者的TIR改善情况优于对照组(,P,<,0.05)。④治疗后,治疗组患者的四肢骨骼肌质量及优势手握力均升高(,P,<,0.05),而对照组患者的四肢骨骼肌质量及优势手握力均降低(,P,<,0.05),且治疗组患者的四肢骨骼肌质量及优势手握力改善情况优于对照组(,P,<,0.05)。⑤治疗后,治疗组患者的HbA1c水平降低(,P,<,0.05),且治疗组患者的HbA1c水平改善情况优于对照组(,P,<,0.05)。,结论,2,健脾清化方可改善初发气阴两虚型T2DM患者的血糖波动,提升优势手握力及四肢骨骼肌含量,改善糖代谢及临床症状,其改善血糖波动的机制可能与改善骨骼肌质量和功能有关。
Objective: To investigate the effects of Jianpi Qinghua Formula on the blood glucose fluctuation and the skeletal muscle content and function in patients of initial type 2 diabetes mellitus (T2DM) with type of qi and yin deficiency.,Methods,2,Seventy patients of initial T2DM with type of qi and yin deficiency were included and randomly divided into the treatment group and control group, 35 cases in each group. The patients in the two groups were given lifestyle intervention. Based on above, the patients in the treatment group were orally treated with Jianpi Qinghua Formula, and the patients in the control group were orally treated with placebo, with a course of 12 weeks. After treatment, the clinical efficacy of the two groups were evaluated and compared. Before and after treatment, the total scores of traditional Chinese medicine (TCM) syndrome were compared between the two groups, and the levels of the time in the target range of blood glucose (TIR), the skeletal muscle mass of extremities, the dominant hand grip strength, and glycosylated hemoglobin (HbA1c), fasting blood glucose (FBG), 2-hour postprandial blood glucose (2 h PBG) were detected.,Results,2,In the course of research, 2 patients in the treatment group and 1 patient in the control group were shed off or removed, finally 33 cases in the treatment group and 34 cases in the control group were included in the statistical analysis. ①After treatment, the total clinical effective rate was 75.8% in the treatment group and 38.2% in the control group, and the therapeutic effect of the treatment group was better than that of the control group (,P,<,0.01). ②After treatment, the total score of TCM syndrome in the treatment group was decreased compared with that before treatment (,P,<,0.05), and the improvement of the total score of TCM syndrome in the treatment group was better than that in the control group (,P,<,0.05). ③After treatment, the TIR of the treatment group showed an upward trend, but there was no statistically significant difference between before and after treatment (,P,>,0.05), the TIR of the control group was significantly decreased (,P,<,0.05), and the improvement of TIR in the treatment group was better than that in the control group (,P,<,0.05). ④After treatment, the skeletal muscle mass of extremities and dominant hand grip strength in the treatment group were increased (,P,<,0.05), while the skeletal muscle mass of extremities and dominant hand grip strength in the control group were decreased (,P,<,0.05), and the improvement of skeletal muscle mass of extremities and dominant hand grip strength in the treatment group was superior to those in the control group (,P,<,0.05). ⑤After treatment, the level of HbA1c in the treatment group was decreased (,P,<,0.05), and the improvement of HbA1c level in the treatment group was superior to that in the control group (,P,<,0.05).,Conclusion,2,Jianpi Qinghua Formula can improve the blood glucose fluctuation, increase the dominant hand grip strength and extremity skeletal muscle content, and improve the glucose metabolism and clinical symptoms in patients of initial T2DM with type of qi and yin deficiency. Its mechanism of improving blood glucose fluctuation may be related to improving the skeletal muscle mass and function.
2型糖尿病气阴两虚型健脾清化方血糖波动骨骼肌中医药疗法
type 2 diabetes mellitustype of qi and yin deficiencyJianpi Qinghua Formulablood glucose fluctuationskeletal muscletraditional Chinese medicine therapy
GORST C, KWOK C S, ASLAM S, et al. Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis[J]. Diabetes Care, 2015, 38(12): 2354-2369.
李红. 糖尿病微血管病变发病机制和治疗靶点[J]. 浙江大学学报(医学版), 2006, 35(3): 233-237.
LI H. Pathogenesis and therapeutic targets of diabetic microvascular complications[J]. Journal of Zhejiang University (Medical Sciences), 2006, 35(3): 233-237.
刘桠,康健,高泓. 从“脾胰同源”论血糖波动的中医辨治思路[J]. 辽宁中医杂志, 2015, 42(7): 1246-1247.
LIU Y, KANG J, GAO H. Discussion Based on Theory of Homogeny of Pi and Yi of Decreasing Glucose Fluctuation of Diabetes by TCM Syndrome Differentiation and Treatment[J]. Liaoning Journal of Traditional Chinese Medicine, 2015, 42(7): 1246-1247.
龚凡,陈清光,韩煦,等. 健脾清化方对2型糖尿病气阴两虚型患者糖脂代谢指标和体质量的影响[J]. 上海中医药杂志, 2020, 54(S1): 55-56, 66.
GONG F, CHEN Q G, HAN X, et al. Effects of Jianpi Qinghua Formula on Glycolipid Metabolism Indexes and Body Mass in Patients of Type 2 Diabetes Mellitus with Syndrome of Deficiency of both Qi and Yin[J]. Shanghai Journal of Traditional Chinese Medicine, 2020, 54(S1): 55-56, 66.
徐隽斐,陈清光,李俊燕,等. 健脾清化方通过调节Wnt10b通路对糖尿病模型大鼠骨骼肌成肌化影响的研究[C]//中华中医药学会糖尿病分会全国中医药糖尿病大会(第十九次)资料汇编. 合肥: 中华中医药学会糖尿病分会全国中医药糖尿病大会, 2018.
XU J F, CHEN Q G, LI J Y, et al. Research on the effect of Jianpi Qinghua Recipe on skeletal muscle myogenesis of diabetic model rats by regulating Wnt10b pathway[C]//Data Compilation of National Conference on Diabetes in Traditional Chinese Medicine, the Diabetes Branch of China Association of Traditional Chinese Medicine (the 19th). Hefei: National Conference on Diabetes in Traditional Chinese Medicine, the Diabetes Branch of China Association of Traditional Chinese Medicine, 2018.
邱艳,谭凌婕,陈清光,等. 健脾清化方对2型糖尿病大鼠肝脏糖异生的影响[J]. 上海中医药大学学报, 2018, 32(4): 82-88.
QIU Y, TAN L J, CHEN Q G, et al. Effects of Jianpi Qinghua Recipe on Hepatic Gluconeogenesis in Rats with Type 2 Diabetes Mellitus[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2018, 32(4): 82-88.
刘亚华,韩煦,金燊懿,等. 健脾清化方调控RasGRP1/P38 MAPK通路影响肠道通透性对高脂饮食诱导肥胖小鼠胰岛素抵抗的改善作用[J]. 中华中医药杂志, 2021,36(5): 2647-2651.
LIU Y H, HAN X, JIN S Y, et al. Effects of Jianpi Qinghua Recipe on improving insulin resistance in DIO mice by regulating RasGRP1/P38 MAPK pathway to affect intestinal permeability[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2021, 36(5): 2647-2651.
韩煦,姚政,李俊燕,等. 健脾清化方对2型糖尿病大鼠肠道免疫细胞Th1/Th2/Th17/Treg的影响[J]. 辽宁中医杂志, 2019, 46(7): 1532-1534.
HAN X, YAO Z, LI J Y, et al. Effects of Jianpi Qinghua Recipe on Intestinal Immune Cells Th1/Th2/Th17/Treg in Type 2 Diabetes Mellitus Rats[J]. Liaoning Journal of Traditional Chinese Medicine, 2019, 46(7): 1532-1534.
徐隽斐,陈清光,俞华芳,等. 健脾清化方对糖尿病大鼠血糖波动和胰岛分泌功能的影响[J]. 世界中西医结合杂志, 2020, 15(7): 1249-1252.
XU J F, CHEN Q G, YU H F, et al. Effects of Jianpi Qinghua Recipe on Blood Sugar Fluctuation and Pancreatic Islet Secretory Function of Diabetic Rats[J]. World Journal of Integrated Traditional and Western Medicine, 2020, 15(7): 1249-1252.
VIJAN S. In the clinic. Type 2 diabetes[J]. Ann Intern Med, 2015,162(5): ITC1-ITC16.
中华中医药学会. 糖尿病中医防治指南[J]. 中国中医药现代远程教育, 2011, 9(4): 148-151.
China Association of Traditional Chinese Medicine. Guide to Traditional Chinese Medicine Prevention and Treatment of Diabetes[J]. Chinese Medicine Modern Distance Education of China, 2011, 9(4): 148-151.
郑莜萸. 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社, 2002: 156-161.
ZHENG X Y. Guiding Principles for Clinical Research of New Drugs of Traditional Chinese Medicine (trial implementation)[M]. Beijing: China Medical Science Press, 2002: 156-161.
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 国际内分泌代谢杂志, 2021, 41(5): 482-548.
Diabetics Branch of Chinese Medical Association. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. International Journal of Endocrinology and Metabolism, 2021, 41(5): 482-548.
ZHANG X L, LU J M, SHAN G L, et al. Association between glucose variability and adverse in-hospital outcomes for Chinese patients with acute coronary syndrome[J]. Saudi Med J, 2010, 31(10): 1146-1151.
CERIELLO A, ESPOSITO K, PICONI L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients[J]. Diabetes, 2008, 57(5): 1349-1354.
刘冰冰,刘国良,赵雪红. 不同波动水平的高糖对大鼠骨骼肌细胞PI-3K表达的影响[J]. 中国病理生理杂志, 2004, 20(1):125-128.
LIU B B, LIU G L, ZHAO X H. Effects of Fluctuant High Concentration of Glucose on Phosphoinositide 3-kinase in Skeletal Muscle Cells[J]. Chinese Journal of Pathophysiology, 2004, 20(1): 125-128.
谢兆桃,周卓宁,郑鹏,等. 从中焦论治2型糖尿病患者餐后血糖波动[J]. 陕西中医, 2021, 42(6): 764-766.
XIE Z T, ZHOU Z N, ZHENG P, et al. Treatment of postprandial blood glucose fluctuation in patients with type 2 diabetes from the perspective of Zhongjiao[J]. Shaanxi Journal of Traditional Chinese Medicine, 2021, 42(6): 764-766.
庞博,赵进喜,王世东,等. 施今墨诊疗糖尿病学术思想与临证经验[J]. 世界中医药, 2013, 8(1): 60-63.
PANG B, ZHAO J X, WANG S D, et al. Shi Jinmo’s academic thought and clinical experience in diagnosis and treatment of diabetes[J]. World Chinese Medicine, 2013, 8(1): 60-63.
富晓旭,刘桠,高泓,等. “脾气散精”环节在机体糖调节中发挥核心作用的理论探讨[J]. 中国中医基础医学杂志, 2021, 27(3): 398-399, 426.
FU X X, LIU Y, GAO H, et al. Theoretical Discussion on the Key Role of “Spleen Qi Dispersing Essence” in the Regulation of Body Sugar[J]. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 2021, 27(3): 398-399, 426.
钟文. 参芪复方防治糖尿病相关性肌少症的作用及机制研究[D]. 成都: 成都中医药大学, 2018.
ZHONG W. Sudy on the Protective Effect of Shenqi Compound on Diabetic Sarcopenia and the Potential Mechanism[D]. Chengdu: Chengdu University of Traditional Chinese Medicine, 2018.
洑晓哲,张耀夫,赵进喜,等. 赵进喜应用鬼箭羽、牛蒡子对药治疗糖尿病肾脏病经验探析[J]. 中华中医药杂志, 2021, 36(8): 4742-4744.
FU X Z, ZHANG Y F, ZHAO J X, et al. Study on the couplet medicines of Euonymus Alatus and Arctii Fructus in treating diabetic kidney disease by ZHAO Jin-xi[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2021, 36(8): 4742-4744.
岳仁宋,白富彬,廖秋双,等. 2型糖尿病血糖波动从脾论治的思路探讨[J]. 辽宁中医杂志, 2011, 38(5): 892-893.
YUE R S, BAI F B, LIAO Q S, et al. Discussion on treatment of blood sugar fluctuation in type 2 diabetes mellitus from spleen[J]. Liaoning Journal of Traditional Chinese Medicine, 2011, 38(5): 892-893.
BARON A D, BRECHTEL G, WALLACE P, et al. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans[J]. Am J Physiol, 1988, 255(6 Pt 1): E769-E774.
SCHEIN A, CORREA A, CASALI K R, et al. Are glucose levels, glucose variability and autonomic control influenced by inspiratory muscle exercise in patients with type 2 diabetes? Study protocol for a randomized controlled trial[J]. Trials, 2016, 17(19): 38-45.
PARK S W, GOODPASTER B H, LEE J S, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes[J]. Diabetes Care, 2009, 32(11): 1993-1997.
0
浏览量
65
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构